TEVA PHARMACEUTICAL INDUSTRIES LTD - 8-K Filing

Teva Pharmaceutical Industries Ltd. amends deposit agreement for mandatory exchange and termination of its American depositary shares program on September 14, 2026. (Items: 3.03 Material Modification to Rights of Security Holders, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $TEVA

Read the full article at SEC EDGAR

More Regulatory news